Capsovision Inc (CV)

Apr 13, 2026

CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN

Apr 13, 2026

Apr 09, 2026

CapsoVision Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsCV - GuruFocus

Apr 09, 2026

Apr 07, 2026

CapsoVision (CV) Schedule 13G/A: CID group, Altenza and individuals report ≤5% holdings - Stock Titan

Apr 07, 2026

Apr 05, 2026

Earnings Preview: CapsoVision to Report Financial Results Post-market on March 26 - Moomoo

Apr 05, 2026

Mar 30, 2026

Major CapsoVision (CV) holder Shen Ching Hang reports large direct and indirect stake - Stock Titan

Mar 30, 2026

Mar 29, 2026

Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2% - MarketBeat

Mar 29, 2026

Mar 27, 2026

Benchmark cuts CapsoVision stock price target to $10 on delayed timeline By Investing.com - Investing.com Australia

Mar 27, 2026

Mar 27, 2026

Benchmark cuts CapsoVision stock price target to $10 on delayed timeline - Investing.com Australia

Mar 27, 2026

Mar 27, 2026

CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark - MarketBeat

Mar 27, 2026

Mar 27, 2026

CapsoVision 2025 Financial Performance Review - AlphaStreet

Mar 27, 2026

Mar 27, 2026

CapsoVision revenue up 13% to USD 3.9M in Q4 2025 - Medical Buyer

Mar 27, 2026

Mar 27, 2026

CapsoVision’s CapsoCam: 360° Panoramic AI-Powered Capsule Endoscopy Solution Expanding Global GI Diagnostics Market 2324323344 - Minichart

Mar 27, 2026

Mar 26, 2026

Large CapsoVision (CV) holder discloses direct and trust share stakes - Stock Titan

Mar 26, 2026

Mar 26, 2026

CapsoVision Q4 2025 Earnings Call Transcript - MarketBeat

Mar 26, 2026

Mar 26, 2026

Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips - Investing.com Australia

Mar 26, 2026

Mar 26, 2026

CapsoVision Q4 Earnings Call Highlights - MarketBeat

Mar 26, 2026

Mar 26, 2026

Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa

Mar 26, 2026

Mar 26, 2026

CapsoVision Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Mar 26, 2026

Mar 26, 2026

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget

Mar 26, 2026

Mar 26, 2026

CV: AI-powered capsule endoscopy drives growth and innovation in noninvasive GI screening - TradingView

Mar 26, 2026

Mar 26, 2026

CapsoVision 10-K: Revenue $13.6M, EPS $(1.03) — Annual Results - TradingView

Mar 26, 2026

Mar 26, 2026

CapsoVision (NASDAQ: CV) flags going concern while advancing AI colon capsule - Stock Titan

Mar 26, 2026

Mar 26, 2026

CapsoVision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener

Mar 26, 2026

Mar 26, 2026

CapsoVision Faces Deadline to Turn Capital Into Profit Before Runway Collapses - Bitget

Mar 26, 2026

Mar 26, 2026

CapsoVision (NASDAQ: CV) grows 2025 revenue 15% as net loss widens - Stock Titan

Mar 26, 2026

Mar 25, 2026

CapsoVision, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 25, 2026

Mar 24, 2026

CapsoVision Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView

Mar 24, 2026

Mar 23, 2026

CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening - MarketBeat

Mar 23, 2026

Mar 23, 2026

CapsoVision price target raised to $11 from $7 at Roth Capital - tipranks.com

Mar 23, 2026

Mar 23, 2026

CapsoVision (CV) director receives 4,045 RSU equity award - Stock Titan

Mar 23, 2026

Mar 23, 2026

CapsoVision (CV) awards 4,045 RSUs to board director - Stock Titan

Mar 23, 2026

Mar 23, 2026

CapsoVision (CV) director receives 4,045 RSU grant as board compensation - Stock Titan

Mar 23, 2026

Mar 23, 2026

CapsoVision (CV) director receives 4,045 RSUs vesting through 2026 - Stock Titan

Mar 23, 2026

Mar 23, 2026

CapsoVision (CV) awards 4,045 restricted stock units to director - stocktitan.net

Mar 23, 2026

Mar 23, 2026

[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan

Mar 23, 2026

Mar 23, 2026

CV: AI-powered capsule endoscopy targets multi-cancer detection with global expansion and strong funding - TradingView

Mar 23, 2026

Mar 23, 2026

CV: CapsoVision advances AI-powered capsule endoscopy with strong pipeline and global expansion - TradingView

Mar 23, 2026

Mar 23, 2026

CapsoVision Closes $14 Mln Private Placement; Reports Preliminary Q4 Revenue Of $3.9 Mln - RTTNews

Mar 23, 2026

Mar 22, 2026

CapsoVision’s Strategic Moves Spike Stock as Market Anticipates Growth - timothysykes.com

Mar 22, 2026

Mar 22, 2026

CapsoVision Surges 13% on Closing $14M Private Placement - StocksToTrade

Mar 22, 2026

Mar 21, 2026

CapsoVision Closes $14 Million Private Placement and Reports Preliminary 2025 Financial Results - Minichart

Mar 21, 2026

Mar 21, 2026

CapsoVision closes $14 million private placement financing By Investing.com - Investing.com Australia

Mar 21, 2026

Mar 20, 2026

CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | H6U | US1409351079 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

CapsoVision Raises Capital and Refocuses Colon Capsule Strategy - TipRanks

Mar 20, 2026

Mar 20, 2026

CapsoVision closes $14 million private placement financing - Investing.com

Mar 20, 2026

Mar 20, 2026

CapsoVision Raises ~$14 Million in Private Placement, Selling 2.87M Shares at $4.883 - tradingview.com

Mar 20, 2026

Mar 20, 2026

CapsoVision (NASDAQ: CV) secures $14M and pivots colon capsule strategy - stocktitan.net

Mar 20, 2026

Mar 20, 2026

CapsoVision Announces $14 Million Private Placement Financing - GlobeNewswire

Mar 20, 2026

Mar 19, 2026

CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | CV | US1409351079 - marketscreener.com

Mar 19, 2026

Mar 19, 2026

What Is CapsoVision's Roadmap For Growth And Innovation In 2026? - RTTNews

Mar 19, 2026